Verona Pharma Logo
A biopharmaceutical company developing and commercializing therapies for chronic respiratory diseases.

About Verona Pharma

We are a biopharmaceutical company developing and commercializing therapies for chronic respiratory diseases. Our initial product, ensifentrine, has received approval from the US FDA.

Our pipeline focuses on chronic lung diseases, including chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis (CF), and non-CF bronchiectasis. COPD is a progressive lung condition that causes breathlessness and has no cure. Cystic fibrosis is a genetic disease marked by mucus buildup and infection. Asthma is a common chronic inflammatory disease affecting airflow in and out of the lungs, and non-CF bronchiectasis involves persistent cough, excess sputum, and frequent respiratory infections.

We were established in 2005 and are listed on the Nasdaq Global Market under the ticker symbol VRNA. Our headquarters are in London, UK, with additional offices in Raleigh and Savannah in the United States.

Mission & Values

Our mission is to develop new treatments that improve the lives of people with chronic lung conditions.

We believe that truly understanding how chronic respiratory conditions affect daily life is key to providing better care for patients.

Team & Culture

Our team has between 201 and 500 employees.

Our management team has proven experience in discovering, developing, and commercializing respiratory therapies.

We foster a patient-focused culture. We emphasize understanding how chronic respiratory conditions affect daily life, which helps us improve patient care.

Frequently Asked Questions

What products or services does the company offer?

Verona Pharma develops and commercializes novel therapies for chronic respiratory diseases. Its first product, ensifentrine, is approved by the US FDA. The company also has a pipeline focused on treatments for conditions such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis (CF), and non-CF bronchiectasis.

What industry does the company operate in?

Verona Pharma operates in biotechnology research, focusing on the development of novel treatments for chronic respiratory diseases.

What is the company's work culture like?

The company’s culture emphasizes a patient-centric approach, focusing on developing treatments to enhance the lives of individuals with chronic lung conditions. It values understanding the impact of these conditions on patients’ daily lives to improve care. The company is led by a management team experienced in respiratory therapy development.

What is Verona Pharma's primary focus?

Verona Pharma’s primary focus is on developing and commercializing therapies for chronic respiratory diseases with significant unmet medical needs. The company aims to enhance the lives of those affected by chronic lung conditions.

When was Verona Pharma founded?

Verona Pharma was founded in 2005.

What industries and sectors does Verona Pharma specialize in?

Verona Pharma is active in the Novel Therapies For Chronic Respiratory Diseases, Copd, Cf, and Asthma markets.

How many people work at Verona Pharma?

Verona Pharma has 201-500 employees.

Where does Verona Pharma hire?

Verona Pharma hires globally with a remote-first approach, allowing employees to work from anywhere.

Is Verona Pharma hiring?

Verona Pharma is not actively hiring at the moment. Check back later for new opportunities.

Does Verona Pharma hire for remote and work from home roles?

Yes, Verona Pharma is a remote-first company.

What is Verona Pharma's website?

Verona Pharma's website is www.veronapharma.com .

Where to find Verona Pharma on social media?

You can find Verona Pharma on LinkedIn .

Remote companies like Verona Pharma

Find your next opportunity with companies that specialize in Novel Therapies For Chronic Respiratory Diseases, Copd, Cf, and Asthma. Explore remote-first companies like Verona Pharma that prioritize flexible work and home-office freedom.

Ascendis Pharma Logo

Ascendis Pharma

A global biopharmaceutical company developing therapies for rare endocrine diseases and cancer using its TransCon technology platform.

View company profile →
Kyverna Therapeutics Logo

Kyverna Therapeutics

A clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases.

View company profile →
REGENXBIO Logo

REGENXBIO

A clinical-stage biotechnology company developing gene therapies for retinal and rare diseases

View company profile →
Adverum Biotechnologies Logo

Adverum Biotechnologies

A clinical-stage company developing gene therapies for prevalent ocular diseases

View company profile →
Alector Logo

Alector

51-200 alector.com

A late-stage clinical biotechnology company developing therapies for neurodegenerative diseases.

View company profile →
Cytokinetics Logo

Cytokinetics

A late-stage biopharmaceutical company developing muscle activators and inhibitors for debilitating muscle diseases.

View company profile →

Project: Career Search

Rev. 2026.3

[ Remote Jobs ]
Direct Access

We source jobs directly from 21,000+ company career pages. No intermediaries.

01

Discover Hidden Jobs

Unique jobs you won't find on other job boards.

02

Advanced Filters

Filter by category, benefits, seniority, and more.

03

Priority Job Alerts

Get timely alerts for new job openings every day.

04

Manage Your Job Hunt

Save jobs you like and keep a simple list of your applications.

21,000+ SOURCES UPDATED 24/7